Unlike MUC1, IL-22 also regulates MUC13 expression via p38 MAPK activation (Figure 9), a signaling pathway involved in TLR4-mediated cell proliferation and immune dysfunction in IBD [48]. Here, TLR4 is linked to inflammatory bowel disease.